BioLineRx Ltd. Increase Decrease Through Exercise Of Options
BioLineRx Ltd. (BLRX) reported Increase Decrease Through Exercise Of Options of $22.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions · last filed 2026-03-23
- BioLineRx Ltd. increase decrease through exercise of options for the quarter ending 2022-06-30 was $2.00K, a 0.00% change year-over-year.
- BioLineRx Ltd. increase decrease through exercise of options for the quarter ending 2021-06-30 was $2.00K, a 100.00% increase year-over-year.
- BioLineRx Ltd. increase decrease through exercise of options for the quarter ending 2020-06-30 was $1.00K.
| Period end | Increase Decrease Through Exercise Of Options 3 month | Increase Decrease Through Exercise Of Options 6 month | Increase Decrease Through Exercise Of Options 12 month | Increase Decrease Through Exercise Of Options 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | $22.00K 20-F · filed 2026-03-23 | |||
| 2023-12-31 | $27.00K 20-F · filed 2026-03-23 | |||
| 2022-12-31 | $5.00K 20-F · filed 2025-03-31 | |||
| 2022-06-30 | $2.00K 6-K · filed 2022-08-16 | $2.00K 6-K · filed 2023-08-30 | ||
| 2021-12-31 | $7.00K 20-F · filed 2024-03-26 | |||
| 2021-06-30 | $2.00K 6-K · filed 2022-08-16 | $7.00K 6-K · filed 2022-08-16 | ||
| 2020-12-31 | $8.00K 20-F · filed 2023-03-22 | -$8.00K 20-F · filed 2021-02-23 | ||
| 2020-06-30 | $1.00K 6-K · filed 2021-08-18 | $8.00K 6-K · filed 2021-08-18 | ||
| 2019-12-31 | $1.00K 20-F · filed 2022-03-16 | -$1.00K 20-F · filed 2020-03-12 | ||
| 2019-06-30 | $1.00K 6-K · filed 2020-08-06 | |||
| 2018-12-31 | -$46.00K 20-F · filed 2021-02-23 |